Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Research Scholarships - Master's program

University of Toronto

$27,000.00

Investigating transcranial direct current stimulation and varenicline as combined strategies for improved smoking cessation outcomes

FY 2025-26

Summary
Quitting smoking remains a major public health challenge, and most smokers relapse within a few months of quitting despite access to medications and various treatment options. This study investigates a new treatment strategy designed to improve long-term quit rates by combining the stop-smoking medication, varenicline, with a safe, non-invasive brain stimulation technique called transcranial direct current stimulation (tDCS). Varenicline, also known as Champix, helps reduce cravings and withdrawal symptoms while tDCS targets the brain regions involved in addiction, decision-making and impulse control. In this study, participants will receive varenicline for 12 weeks while attending tDCS sessions in which a mild electrical current is applied to the scalp to modulate the excitability of the neurons in the targeted brain region. The goal is to determine whether this combined treatment leads to higher quit rates in smokers when compared to varenicline alone. In addition to measuring smoking outcomes, this study will assess the attention and memory of each participant using computer-based tasks since these cognitive functions are often impacted during nicotine withdrawal. By exploring this new treatment approach, this research aims to identify a more effective and accessible option for smoking cessation. If successful, this combined intervention could expand treatment options for people trying to quit smoking in Canada, offering a promising new tool to support long-term recovery from smoking tobacco.
Program
Master's Award: Canada Graduate Research Scholarships - Master's program
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
582155
Name
Doray Kamrani
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Investigating transcranial direct current stimulation and varenicline as combined strategies for improved smoking cessation outcomes
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Research Scholarships - Master's program
Keyworddelim
Acceptability; Adjunct Treatment; Brain Stimulation; Feasibility; Neuromodulation; Neuropharmacology; Pharmacology; Smoking Cessation; Transcranial Direct Current Stimulation; Varenicline
Abstract
Quitting smoking remains a major public health challenge, and most smokers relapse within a few months of quitting despite access to medications and various treatment options. This study investigates a new treatment strategy designed to improve long-term quit rates by combining the stop-smoking medication, varenicline, with a safe, non-invasive brain stimulation technique called transcranial direct current stimulation (tDCS). Varenicline, also known as Champix, helps reduce cravings and withdrawal symptoms while tDCS targets the brain regions involved in addiction, decision-making and impulse control. In this study, participants will receive varenicline for 12 weeks while attending tDCS sessions in which a mild electrical current is applied to the scalp to modulate the excitability of the neurons in the targeted brain region. The goal is to determine whether this combined treatment leads to higher quit rates in smokers when compared to varenicline alone. In addition to measuring smoking outcomes, this study will assess the attention and memory of each participant using computer-based tasks since these cognitive functions are often impacted during nicotine withdrawal. By exploring this new treatment approach, this research aims to identify a more effective and accessible option for smoking cessation. If successful, this combined intervention could expand treatment options for people trying to quit smoking in Canada, offering a promising new tool to support long-term recovery from smoking tobacco.
Competitiondate
202512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Doray, Kamrani
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~